- Home
- CELC vs BSRR Comparison
CELC vs BSRR Comparison
Compare CELC & BSRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELC
- BSRR
- Stock Information
- Founded
- CELC 2011
- BSRR 1977
- Country
- CELC United States
- BSRR United States
- Employees
- CELC N/A
- BSRR N/A
- Industry
- CELC Medical Specialities
- BSRR Major Banks
- Sector
- CELC Health Care
- BSRR Finance
- Exchange
- CELC Nasdaq
- BSRR Nasdaq
- Market Cap
- CELC 327.3M
- BSRR 349.2M
- IPO Year
- CELC 2017
- BSRR 1994
- Fundamental
- Price
- CELC $10.15
- BSRR $26.84
- Analyst Decision
- CELC Strong Buy
- BSRR Buy
- Analyst Count
- CELC 6
- BSRR 3
- Target Price
- CELC $30.17
- BSRR $33.50
- AVG Volume (30 Days)
- CELC 190.9K
- BSRR 33.6K
- Earning Date
- CELC 05-14-2025
- BSRR 04-28-2025
- Dividend Yield
- CELC N/A
- BSRR 3.71%
- EPS Growth
- CELC N/A
- BSRR 17.05
- EPS
- CELC N/A
- BSRR 2.83
- Revenue
- CELC N/A
- BSRR $144,262,000.00
- Revenue This Year
- CELC N/A
- BSRR $7.75
- Revenue Next Year
- CELC N/A
- BSRR $4.30
- P/E Ratio
- CELC N/A
- BSRR $9.52
- Revenue Growth
- CELC N/A
- BSRR 1.70
- 52 Week Low
- CELC $7.58
- BSRR $19.77
- 52 Week High
- CELC $19.77
- BSRR $35.13
- Technical
- Relative Strength Index (RSI)
- CELC 46.58
- BSRR 50.84
- Support Level
- CELC $9.64
- BSRR $26.16
- Resistance Level
- CELC $10.80
- BSRR $27.51
- Average True Range (ATR)
- CELC 0.66
- BSRR 1.04
- MACD
- CELC -0.06
- BSRR 0.17
- Stochastic Oscillator
- CELC 25.25
- BSRR 74.13
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About BSRR Sierra Bancorp
Sierra Bancorp is a California-based bank holding company, which offers a range of retail and commercial banking services. it offers a wide range of deposit products and services for individuals and businesses including checking accounts, savings accounts, money market demand accounts, time deposits, retirement accounts, and sweep accounts. The company's lending activities cover real estate, commercial (including small business), mortgage warehouse, agricultural and consumer loans, and also offers commercial construction loans and multifamily and agricultural credit facilities among other types of real estate loans.